334 related articles for article (PubMed ID: 25676786)
1. A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.
Banuelos J; Shin SC; Lu NZ
Steroids; 2015 Apr; 96():115-20. PubMed ID: 25676786
[TBL] [Abstract][Full Text] [Related]
2. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?
Ray A; LaForge KS; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7086-90. PubMed ID: 1871124
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
Ramos RA; Meilandt WJ; Wang EC; Firestone GL
FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
[TBL] [Abstract][Full Text] [Related]
4. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S
J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
6. Helix 8 of the ligand binding domain of the glucocorticoid receptor (GR) is essential for ligand binding.
Deng Q; Waxse B; Riquelme D; Zhang J; Aguilera G
Mol Cell Endocrinol; 2015 Jun; 408():23-32. PubMed ID: 25676569
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
8. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
9. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
[TBL] [Abstract][Full Text] [Related]
10. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
11. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.
Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S
Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.
Powers JH; Hillmann AG; Tang DC; Harmon JM
Cancer Res; 1993 Sep; 53(17):4059-65. PubMed ID: 8358735
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of R651 mutations in the putative helix 6 of rat glucocorticoid receptors.
Huang Y; Simons SS
Mol Cell Endocrinol; 1999 Dec; 158(1-2):117-30. PubMed ID: 10630412
[TBL] [Abstract][Full Text] [Related]
15. Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells.
Jewell CM; Scoltock AB; Hamel BL; Yudt MR; Cidlowski JA
Mol Endocrinol; 2012 Feb; 26(2):244-56. PubMed ID: 22174376
[TBL] [Abstract][Full Text] [Related]
16. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
18. Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-Binding Domains.
Hurt DE; Suzuki S; Mayama T; Charmandari E; Kino T
Mol Endocrinol; 2016 Feb; 30(2):173-88. PubMed ID: 26745667
[TBL] [Abstract][Full Text] [Related]
19. Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action.
Li G; Wang S; Gelehrter TD
J Biol Chem; 2003 Oct; 278(43):41779-88. PubMed ID: 12902338
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the N-terminal end of the glucocorticoid receptor hormone binding domain.
Milhon J; Kohli K; Stallcup MR
J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):11-9. PubMed ID: 7947345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
